soul trial oral semaglutide cardiovascular outcomes 2025 nejm 2024 Oral Semaglutide's Impact on Cardiovascular Events in Type 2 Diabetes Patients with Cardiovascular and Kidney Disease: SOUL Trial Results Study Finds Oral Semaglutide Vastly

Any bacteria introduced during the prefilling process can multiply freely

At these lower initial doses, the appetite-suppressing and metabolic effects of semaglutide are present but not yet at their maximum potential

Safety Considerations With Compounded GLP-1 Medications Discussions about GLP-1 microdosing often involve compounded medications, which are versions of tirzepatide or semaglutide mixed by compounding pharmacies rather than manufactured by the original drug maker

For those with blood disorders like thrombocytopenia (low platelet count) or von Willebrand disease , bruising risks are significantly higher

Slows Digestion and Increases Satiety GLP-1 also slows digestion and contributes to a full sensation